Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-07
2006-11-07
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210190, C514S210200, C514S210210, C544S335000, C546S172000, C546S268100, C548S314700, C548S518000, C548S953000
Reexamination Certificate
active
07132414
ABSTRACT:
The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula:in which R1represents a radical —NHCOR4or —N(R5)—Y—R6, Y is CO or SO2, R4represents a radical -alk-SO2—R11, -alk-SO2—CH═CH—R11or Het substituted with —SO2—R11or a phenyl radical substituted with —SO2—R11or -alk-SO2—R11, R5represents a hydrogen atom or an alkyl radical, R6represents a phenylalkyl, Het or Ar radical, to the novel derivatives of formula (I) and to their preparation, as well s to their use in treating various disorders of the nervous system.
REFERENCES:
patent: 4242261 (1980-12-01), Cale, Jr.
patent: 0 406 112 (1994-12-01), None
patent: WO97/01556 (1997-01-01), None
patent: WO 99/01451 (1999-01-01), None
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, vol. 2, 1996, pp. 1992-1996.
Layzer, Degenerative Diseases of the Nervious System, 20th Edition, vol. 2, 1996, pp. 2050-2057.
Pertwee, Canabinoid Receptor Ligands, Tocris Reviews, No. 16, Apr. 2001, pp. 1-8.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, 1996, pp. 1004-1010.
Consroe et al, Potential Role of Cannabinolds for Therapy of Neurological Disorders, Marijuana/Cannabinoids Neurobiology and Neurophysiology, Murphy L. and Barthe A. Eds., CRC Press, vol. 459, 1992, pp. 459-524.
Dave, Acylative Dealkylation of N-tert-Butyl-3-substituted Azetidines: Facil Access to [1.1.0]Azabicyclobutane, 3-Hydroxyazetidinium Hydrochloride, and 3-Azetidinones, J. Org. Chem., vol. 61, 1996, pp. 5454-5455.
Hollister, Health Aspects of Canabis, Pharm. Rev., vol. 38, No. 1, 1986, pp. 1-20.
Katritzky et al, Novel Syntheses of 1,3,3-Trinitroazetidine, J. Heterocycl. Chem. vol. 271, 31, 1994, pp. 271-275.
Kuster et al, Aminoalkylindole Binding in Rat Cerebelium: Selective Displacement by Natural and Synthetic Cannabinoids, J. Pharmacol. Exp. Ther., vol. 264, No. 3, 1993, pp. 1352-1363.
Pertwee, Effects of cannabinoids on thermoregulation: a brief review, Marihuana '84 Proceedings of the Oxford Symposium on Cannabis, Marijuana, Harvey d. J. Eds, 1985, pp. 263-277.
Seth et al, Chemistry and Pharmacology of Cannabis, Progress in Drug Research, 1991, pp. 71-114.
Maneuf, Y.P., et. al., Cannabinold Receptor-Mediated Modulation of Gabaergic Transmission in the Basal Ganglia Implications for the Treatment of Parkinson's Disease?, The Basal Ganglia V, Plenum Press, New York, vol. 21, (1996) pp. 183-189.
Maneuf, Y.P., et al., The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D2, but not D1, Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease, Experimental Nerology vol. 148, pp. 265-270 (1997).
Pertwee, R.G., et. al., Neuropharmacology and Therapeutic Potential of Cannabinoids, Addiction Biology (2000) vol. 5, pp. 37-46.
Puffenbarger, R.A., et. al., Molecular Biology of the Enzymes that Degrade Endocannabinoids, Current Drug Targets—CNS & Neurological Disorders—(2005) vol. 4, pp. 625-631.
Westlake, W.M., et. al., Cannabinoid Receptor Binding and Messenger RNA Expression in Human Brain: An Invitro Receptor Autoradiography and In Situ Hybridization Histochemistry Study of Normal Aged and Alzheimer's Brains, Neuroscience vol. 63, No. 3, pp. 637-652 (1994).
Achard Daniel
Bouchard Herve
Bouquerel Jean
Filoche Bruno
Grisoni Serge
Aventis Pharma S.A.
Newman Irving
Rao Deepak
LandOfFree
Pharmaceutical compositions containing 3-aminoazetidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing 3-aminoazetidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing 3-aminoazetidine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674530